CollPlant Biotechnologies Ltd.
CLGN
$1.47
-$0.03-2.00%
NASDAQ
| 12/31/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | ||
|---|---|---|---|---|---|
| Revenue | 164.00K | 249.00K | 98.00K | 299.00K | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | 164.00K | 249.00K | 98.00K | 299.00K | |
| Cost of Revenue | 272.00K | 536.00K | 545.00K | 773.00K | |
| Gross Profit | -108.00K | -287.00K | -447.00K | -474.00K | |
| SG&A Expenses | 1.32M | 1.42M | 1.48M | 1.48M | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 4.14M | 4.66M | 4.43M | 5.37M | |
| Operating Income | -3.97M | -4.41M | -4.33M | -5.07M | |
| Income Before Tax | -3.88M | -4.21M | -4.20M | -4.69M | |
| Income Tax Expenses | -- | -- | -- | -- | |
| Earnings from Continuing Operations | -3.88M | -4.21M | -4.20M | -4.69M | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -3.88M | -4.21M | -4.20M | -4.69M | |
| EBIT | -3.97M | -4.41M | -4.33M | -5.07M | |
| EBITDA | -3.73M | -4.15M | -4.05M | -4.78M | |
| EPS Basic | -0.34 | -0.37 | -0.37 | -0.41 | |
| Normalized Basic EPS | -0.21 | -0.23 | -- | -0.26 | |
| EPS Diluted | -0.34 | -0.37 | -0.37 | -0.41 | |
| Normalized Diluted EPS | -0.21 | -0.23 | -- | -0.26 | |
| Average Basic Shares Outstanding | 11.45M | 11.45M | 11.45M | 11.45M | |
| Average Diluted Shares Outstanding | 11.45M | 11.45M | 11.45M | 11.45M | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |